Please assess the completion status of the following clinical trial:

Trial Title: Comparison of Insulin Detemir Morning, Insulin Detemir Evening and NPH Insulin Evening in Patients With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Type 2 diabetes for at least 12 months~* Currently treated with Oral Antidiabetic Drugs~* BMI lesser than or equal to 40 kg/m2~* HbA1c greater than or equal 7.5 and lesser than or equal to 11%~Exclusion Criteria:~* Proliferative retinopathy or maculopathy~* Recurrent major hypoglycaemia~* uncontrolled hypertension or any disease or condition (such as renal, hepatic or cardiac) that according to the judgement of the Investigator makes the subject unsuitable for participation in the trial

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).